硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 SCGB3A2 抗体对
试剂盒

人 SCGB3A2 抗体对

01AB01831

Secretoglobin family 3A member 2 (SCGB3A2) is a secreted lung surfactant and cytokine-like protein primarily expressed in airway club cells under the regulation of thyroid transcription factor-1. It functions as a critical modulator of respiratory homeostasis by binding the scavenger receptor MARCO and inhibiting secreted phospholipase A2 (PLA2G1B), which mediates its potent anti-inflammatory and anti-fibrotic effects. During development, SCGB3A2 promotes branching morphogenesis and maturation of the fetal lung. It also interacts with microbial pathogens and may influence pituitary hormone production. Clinically, SCGB3A2 is associated with susceptibility to asthma and interstitial lung disease, where its downregulation or genetic polymorphism contributes to chronic airway inflammation. Recombinant SCGB3A2 has shown potential in suppressing allergic airway responses, highlighting its protective role in the respiratory epithelium.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
SCGB3A2
基因别名
PNSP1; UGRP1
蛋白别名
secretoglobin family 3A member 2; SCGB3A2
UniProt
Q96PL1
物种
Human

产品详情

靶点名称
SCGB3A2
蛋白名称
secretoglobin family 3A member 2
蛋白别名
Secretoglobin family 3A member 2; Pneumo secretory protein 1; PnSP-1; Uteroglobin-related protein 1
靶点基因名
SCGB3A2
基因别名
PNSP1; UGRP1
UniProt
Q96PL1
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Secretoglobin family 3A member 2 (SCGB3A2) is a secreted lung surfactant and cytokine-like protein primarily expressed in airway club cells under the regulation of thyroid transcription factor-1. It functions as a critical modulator of respiratory homeostasis by binding the scavenger receptor MARCO and inhibiting secreted phospholipase A2 (PLA2G1B), which mediates its potent anti-inflammatory and anti-fibrotic effects. During development, SCGB3A2 promotes branching morphogenesis and maturation of the fetal lung. It also interacts with microbial pathogens and may influence pituitary hormone production. Clinically, SCGB3A2 is associated with susceptibility to asthma and interstitial lung disease, where its downregulation or genetic polymorphism contributes to chronic airway inflammation. Recombinant SCGB3A2 has shown potential in suppressing allergic airway responses, highlighting its protective role in the respiratory epithelium.